Myriad Genetics News
Most Popular Myriad Genetics Story
Lilly readies Phase III Alzheimer's trial
Struggling to right itself after a long dry spell in new drug approvals, Eli Lilly is preparing to a launch a late-stage study of an experimental drug for Alzheimer's. LY450139 is expected to inhibit Read more...
Latest Headlines
- November 1, 2010
- October 27, 2010
- October 15, 2010
- April 19, 2010
- March 31, 2010
- February 5, 2010
- December 18, 2009
- January 21, 2009
- December 19, 2008
- October 21, 2008
- September 11, 2008
- August 20, 2008
- June 30, 2008
- May 30, 2008
- March 31, 2008
- January 7, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
